UGT1A1 and Hepatic steatosis: Experimental studies in mice with the human Gilbert’s syndrome polymorphism (UGT1A1*28) were shown to have moderate hyperbilirubinemia and were protected from high-fat diet-induced hepatic steatosis (NAFLD) and insulin resistance [50].